Template:ICD10 Guideline Combined dx metastasis primary: Difference between revisions

Revision as of 01:45, 22 November 2017

This template is used for the Candidate Combined ICD10 codes section of ICD10 diagnosis articles that are

To use:

{{Combined dx metastasis primary}}

Malignancy with Metastasis

Metastasis and their primary tumor should be coded in combination because the codes for mets don't specify the primary site, only the site of the mets.

Codes for the mets can be found at:

Metastasis codes:
Adrenal gland, metastatic malignancy to it (also code primary site) Bone or bone marrow, metastatic malignancy to it (also code primary site) Brain or meninges, metastatic malignancy to it (also code primary site) Gastrointestinal system NOS, metastatic malignancy to it (also code primary site) Liver or biliary system, metastatic malignancy to it (also code primary site) Lung, metastatic malignancy to it (also code primary site) Lymph nodes, metastatic malignancy to them (also code primary site) Peritoneum, metastatic malignancy to it (also code primary site) Pleura, metastatic malignancy to it (also code primary site) Respiratory system NOS, metastatic malignancy to it (also code primary site) Site NOS, metastatic malignancy to it (also code primary site) Urinary system NOS, metastatic malignancy to it (also code primary site)

If the site of the mets isn't in the list, use Site NOS, metastatic malignancy to it (also code primary site)
If there are mets to multiple sites, then combine all together the primary malignancy code to the codes for the different sites of the mets.

Codes for the primary tumors can be found at:

Neoplastic codes:
Acute erythroblastic leukemia (erythroleukemia) Acute lymphoblastic leukemia (ALL) Acute megakaryoblastic leukemia Acute myeloid leukemia (AML) Acute myelomonocytic leukaemia (AMML) Acute promyelocytic leukaemia (APL) Adrenal gland, benign neoplasm Adrenal gland, metastatic malignancy to it (also code primary site) Adrenal gland, primary malignancy Antineoplastic/chemotherapy or immunosuppressive drugs, adverse effect Antineoplastic/chemotherapy or immunosuppressive drugs, overdose/toxicity Benign neoplasm, NOS Biliary tract, primary malignancy Bladder, primary malignancy Bone NOS, pathologic fracture due to neoplastic disease Bone or bone marrow, metastatic malignancy to it (also code primary site) Bone or cartilage (any location), primary malignancy Bone or cartilage, benign neoplasm Brain or meninges, metastatic malignancy to it (also code primary site) Brain, primary malignancy Breast, benign neoplasm Breast, primary malignancy Carcinoid syndrome Carcinoma in situ, any site Central nervous system NOS, benign neoplasm Central nervous system NOS, primary malignancy Cervix, dysplasia Cervix, primary malignancy Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Colon (large intestine) or rectum or anus, benign neoplasm Colon (large intestine), primary malignancy Connective or soft tissue NOS (external or internal), primary malignancy Digestive system NOS, benign neoplasm Disorder of anus or rectum, NOS Endocrine gland NOS, benign neoplasm Endocrine gland NOS, primary malignancy Esophagus, benign neoplasm Esophagus, primary malignancy Essential thrombocythemia/thrombocytosis Eye or related structures, benign neoplasm Eye, primary malignancy Fat, benign neoplasm Female genitalia NOS (internal or external), primary malignancy Female genitals, benign neoplasm Femur or pelvis, pathologic fracture due to neoplastic disease GI organ NOS, primary malignancy Gallbladder, primary malignancy Gastrointestinal system NOS, metastatic malignancy to it (also code primary site) Genetic susceptibility to malignant neoplasm Hairy cell leukemia Head and neck and face, primary malignancy Heart, benign neoplasm Heart, primary malignancy Hemangioma or lymphangioma, benign neoplasm, any site Hodgkin's lymphoma (Hodgkin's disease) Hypercalcemia Intrathoracic structures NOS, benign neoplasm Kaposi's sarcoma Kidney or ureter or bladder or urethra, benign neoplasm Kidney, primary malignancy Larynx, benign neoplasm Larynx, primary malignancy Leukemia, NOS Lip or mouth or tonsils or pharynx, primary malignancy Liver or biliary system, benign neoplasm Liver or biliary system, metastatic malignancy to it (also code primary site) Liver, primary malignancy Lung and/or bronchus, primary malignancy Lung or bronchi, benign neoplasm Lung, metastatic malignancy to it (also code primary site) Lymph nodes, benign neoplasm Lymph nodes, metastatic malignancy to them (also code primary site) Lymphoid leukemia, NOS Lymphoma, NOS Male genitalia NOS (internal or external), primary malignancy Male genitals, benign neoplasm Malignancy (clonal disorder) of blood or lymphoid tissue, NOS Malignant carcinoid tumor Malignant immunoproliferative disease Mediastinum, primary malignancy Meninges, benign neoplasm Meninges, primary malignancy Mesothelioma (any site) Monoclonal gammopathy of undetermined significance (MGUS) Monocytic leukemia, acute or chronic Mouth or pharynx or salivary glands, benign neoplasm Multiple endocrine adenomatosis (multiple endocrine neoplasia syndrome, MEN) Multiple myeloma Myelodysplastic syndrome/myelodysplasia (preleukemia, refractory anemia) Myeloproliferative diseases Nasal cavity or sinus or middle ear, primary malignancy Neoplasm of uncertain behavior (i.e. not clear if benign or malignant), NOS Nerves, peripheral or autonomic, primary malignancy Nerves, peripheral, benign neoplasm Non-Hodgkin's lymphoma Ovary, benign neoplasm Ovary, primary malignancy Pancreas, benign neoplasm Pancreas, primary malignancy ... further results

Revision as of 19:58, 21 November 2017 view source Ttenbergen (talk \| contribs) CCMDB_legit, admin, approved, Bureaucrats, Interface administrators, Administrators (Semantic MediaWiki), Curators (Semantic MediaWiki), Administrators 91,904 edits mNo edit summary ← Older edit		Revision as of 01:45, 22 November 2017 view source Ttenbergen (talk \| contribs) CCMDB_legit, admin, approved, Bureaucrats, Interface administrators, Administrators (Semantic MediaWiki), Curators (Semantic MediaWiki), Administrators 91,904 edits mNo edit summary Newer edit →
Line 18:		Line 18:
	*If there are mets to multiple sites, then combine all together the primary malignancy code to the codes for the different sites of the mets.		*If there are mets to multiple sites, then combine all together the primary malignancy code to the codes for the different sites of the mets.

	Codes for ~~teh~~ primary tumors can be found at: {{ListICD10Category \| categoryName = Neoplastic}}		Codes for the primary tumors can be found at: {{ListICD10Category \| categoryName = Neoplastic}}

Template:ICD10 Guideline Combined dx metastasis primary: Difference between revisions

Revision as of 01:45, 22 November 2017

Malignancy with Metastasis

Navigation menu

Search